BioServe: Cancer Genetics acquires BioServe India
US-based Cancer Genetics (CGI) has completed the acquisition of BioServe Biotechnologies (India) for $1.9m, which provides genomics services that cover both the research and clinical markets in India.
Read full article »
BioServe is a biotechnology firm that engages in DNA synthesis, sequencing and related services.
Read more